Gymnema Sylvestre
Gymnema sylvestre botanical products marketed for glucose control and sweet-taste effects. Meta-analytic signals arise from small heterogeneous trials and should not be generalized across extracts or replace diabetes treatment.
Pharmacokinetic model
A route-level PK model for gymnema sylvestre is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Herb
- Suggested cadence
- once daily
Research behind this entry
-
The effects of Gymnema Sylvestre supplementation on lipid profile, glycemic control, blood pressure, and anthropometric indices in adults: A systematic review and meta-analysis
Meta-analysis reported changes in selected glycemic and lipid outcomes, but trials were small and differed in populations, products, doses, and background treatment. Certainty and product generalizability remain limited.
-
Gymnema sylvestre for Diabetes: From Traditional Herb to Future's Therapeutic
Narrative review describes traditional use, chemistry, mechanisms, and early clinical observations. It is not a confirmatory efficacy trial and does not define standardized exposure.
-
Comparative Effects of Gymnema sylvestre and Berberine on Adipokines, Body Composition, and Metabolic Parameters in Obese Patients: A Randomized Study.
This citation reports a human clinical study involving Gymnema Sylvestre. It does not by itself establish a qualified dose, safety profile, efficacy claim, or pharmacokinetic route for this record.
3 published studies referenced in the app, each with a plain-language summary.